The trademark ROXALTO was filed by ADAMED PHARMA S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on February 21, 2021, and received one opposition filed on May 20, 2021 by Otsuka Pharmaceutical Co., Ltd. on Likelihood of confusion. the opponent was represented by HOGAN LOVELLS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 20, 2021
The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 11, 2021. Appointment and Replacement of representative of the trademark registration was recorded on December 18, 2023.
The Appeal with reference B R0787/2023-4 was Opposition rejected according to Article 8(1)(b) EUTMR with decision issued on December 19, 2023 by the EUIPO. The Opposition with reference B 003147315 was rejected according to Article 8(1)(b) EUTMR with decision issued on February 18, 2023 by the EUIPO.